Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
Guidelines for the sexual and reproductive health of people living with HIV - consultation open

These BHIVA / BASHH / FSRH guidelines are an update to the 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection (PLWH). They are open for consultation to Friday 8 December 2017.

Published
13 October 2017
From
BHIVA
BHIVA response to BMJ article on ART in pregnant women living with HIV

We do not support recommendations of "ART in pregnant women living with HIV: a clinical practice guideline" (BMJ, 11/9/17). Other systematic reviews and numerous observational studies show tenofovir to be safe in HIV in pregnancy.

Published
25 September 2017
From
BHIVA
Chronic pain common in people living with HIV

HIVMA comprehensive guidelines recommend screening everyone with HIV, offering multidisciplinary treatment focusing on non-drug options.

Published
14 September 2017
From
EurekAlert
New guidelines recommend that women avoid tenofovir & emtricitabine during pregnancy

Women should be offered the choice to avoid treatment with tenofovir and emtricitabine during pregnancy owing to a higher risk of stillbirth and early infant

Published
13 September 2017
By
Keith Alcorn
Alice Welbourn: WHO and the rights of women living with HIV

A recent set of articles on HIV in pregnancy, published by The BMJ and BMJ Open, raises concerns that some combination anti-retroviral therapies (cARTs) may harm babies. This highlights the need for changes to current WHO practice towards pregnant women living with HIV, which is no doubt well-intentioned but ill thought-out.

Published
12 September 2017
From
BMJ Opinion
Who Resists Starting ART Therapy for HIV?

The study found that the demographic characteristics of patients who failed to initiate ART within 2 years of entering care were not as important as clinical factors. Higher CD4 count, lower viral load, and a prevalent AIDS diagnosis were clinical characteristics associated with delayed ART initiation.

Published
07 September 2017
From
MD Mag
No evidence of reduced efficacy or increased side-effects when patients switch to generic drugs, comparison study finds

An analysis of 440 people switched to generic antiretroviral drugs at an Italian clinic and a matched cohort of patients who remained on their branded medication has

Published
24 August 2017
By
Roger Pebody
Globally, People With HIV Are Starting Treatment Earlier

But the median CD4 count at treatment start is below 350, which means work is needed to catch up to World Health Organization guidelines.

Published
21 August 2017
From
Poz
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Everyone diagnosed with HIV should be offered the option to start treatment within seven days of diagnosis and everyone who feels ready should have the option to

Published
25 July 2017
By
Keith Alcorn
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.

Published
23 July 2017
From
World Health Organization
← First12345...34Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.